ArticleBreast cancer research : BCR2019

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas.

Ilianna Zoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.